Flucytosine

氟胞嘧啶

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFlucytosine
Drug Alias NameFluorocytosine5-氟胞嘧啶flucytosinumflucytosineflucitosina +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsColorectal NeoplasmsDigestive System NeoplasmsCarcinoma, Hepatocellular +[5] 
Global Approved IndicationsMycoses
Approved Indications in ChinaMycoses
Original Approved Country/TerritoryUnited States
Original Approved Date1971/11/26
Country/TerritoryBelgiumUnited StatesUganda +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBausch Health Companies Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MinnesotaBausch & Lomb (Singapore) Pvi LtdNantong Jinghua Pharmaceutical Co Ltd
Inactive CompaniesTransgene Sa
Active IndicationsMeningitis, CryptococcalMycoses
Inactive IndicationsColorectal NeoplasmsDigestive System NeoplasmsCarcinoma, Hepatocellular

Other Information

ATC CodeD01AE21J02AX01
Related LinksWikipediaDrugBankKEGG